Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlorothiazide sodium |
Is a |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorothiazide measurement |
Component |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental chlorothiazide poisoning |
Causative agent (attribute) |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional chlorothiazide poisoning |
Causative agent (attribute) |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la chlorothiazide d'intention indéterminée |
Causative agent (attribute) |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide adverse reaction |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide allergy |
Causative agent (attribute) |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorothiazide overdose |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental chlorothiazide overdose (disorder) |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional chlorothiazide overdose |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de chlorothiazide d'intention indéterminée |
Causative agent (attribute) |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorothiazide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by chlorothiazide |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing chlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chlorothiazide and reserpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide- and methyldopa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely chlorothiazide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental chlorothiazide poisoning |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Intentional chlorothiazide poisoning |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing chlorothiazide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide allergy |
Causative agent (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 250 mg oral tablet |
Has precise active ingredient |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 500 mg oral tablet |
Has precise active ingredient |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet |
Has precise active ingredient |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet |
Has precise active ingredient |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing chlorothiazide and reserpine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing chlorothiazide and methyldopa in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 50 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide 50 mg/mL oral suspension |
Has precise active ingredient |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide and methyldopa only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorothiazide and reserpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorothiazide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide and methyldopa only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorothiazide and reserpine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorothiazide sodium |
Is modification of (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely chlorothiazide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorothiazide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Chlorothiazide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |